Predispensing of antivirals to high-risk individuals in an influenza pandemic (Q30383781)

20 August 2017

Predispensing of antivirals to high-risk individuals in an influenza pandemic (English)

1 reference

20 August 2017

0 references

1 reference

4

Marc Lipsitch

0 references

Joel C. Miller

object named as

Joel C Miller

series ordinal

2

0 references

Edward Goldstein

series ordinal

1

object named as

Edward Goldstein

1 reference

20 August 2017

Justin O'Hagan

3

1 reference

20 August 2017

21 August 2009

1 reference

20 August 2017

1 reference

20 August 2017

1

1 reference

20 August 2017

RRN1007

1 reference

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Antiviral usage for H1N1 treatment: pros, cons and an argument for broader prescribing guidelines in the United States.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

H1N1 2009 influenza virus infection during pregnancy in the USA.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Antiviral resistance and the control of pandemic influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Prevalence of overweight and obesity in the United States, 1999-2004

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Early administration of oral oseltamivir increases the benefits of influenza treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Antimicrobial use and antimicrobial resistance: a population perspective

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Oseltamivir: a review of its use in influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762331

26 November 2018

Identifiers

DOI

10.1371/CURRENTS.RRN1007

0 references

PMC publication ID

2762331

1 reference

PMC publication ID

2762331

20 August 2017

PubMed publication ID

20029604

1 reference

PMC publication ID

2762331